Table 1.
Baseline prevalence of anogenital HPV infection in 3817 women aged 24 to 45 years, by country.
HPV type | Total |
Colombia |
France |
Germany |
Philippines |
Spain |
Thailand |
United States |
---|---|---|---|---|---|---|---|---|
N = 3817 |
N = 1610 |
N = 106 |
N = 310 |
N = 400 |
N = 65 |
N = 782 |
N = 544 |
|
% | % | % | % | % | % | % | % | |
6 | 1.9 | 1.8 | 6.7 | 4.6 | 0.8 | 3.1 | 0.3 | 2.6 |
11 | 0.2 | 0.3 | 0.0 | 0.7 | 0.0 | 0.0 | 0.4 | 0.0 |
16 | 4.5 | 4.9 | 9.6 | 7.8 | 1.8 | 4.8 | 1.8 | 6.4 |
18 | 2.1 | 2.2 | 1.9 | 3.3 | 0.8 | 1.6 | 0.6 | 4.3 |
31 | 2.8 | 3.2 | 8.7 | 5.6 | 0.8 | 7.9 | 0.8 | 2.6 |
33 | 0.7 | 0.8 | 1.9 | 1.0 | 0.0 | 0.0 | 0.8 | 0.7 |
35 | 1.3 | 2.0 | 1.0 | 0.3 | 0.3 | 1.6 | 0.1 | 2.4 |
39 | 3.0 | 3.4 | 2.9 | 2.6 | 0.8 | 1.6 | 2.3 | 4.8 |
45 | 1.7 | 1.9 | 1.0 | 2.3 | 1.3 | 4.8 | 0.4 | 3.0 |
51 | 3.8 | 4.1 | 9.6 | 5.9 | 1.8 | 4.8 | 1.8 | 4.5 |
52 | 4.5 | 5.1 | 9.6 | 3.6 | 2.6 | 3.2 | 3.9 | 5.0 |
56 | 6.4 | 8.0 | 8.7 | 10.5 | 2.0 | 14.3 | 1.4 | 8.2 |
58 | 2.7 | 4.3 | 1.9 | 2.3 | 0.8 | 0.0 | 1.2 | 2.0 |
59 | 2.2 | 2.5 | 5.8 | 3.3 | 1.3 | 0.0 | 1.0 | 2.8 |
6/11 | 2.1 | 2.1 | 6.7 | 4.6 | 0.8 | 3.1 | 0.6 | 2.6 |
16/18 | 6.2 | 6.8 | 11.5 | 10.1 | 2.0 | 6.5 | 2.3 | 9.9 |
6/11/16/18 | 7.9 | 8.6 | 15.4 | 13.7 | 2.8 | 8.1 | 3.0 | 12.0 |
31/33/45/52/58 | 10.7 | 13.1 | 19.0 | 12.4 | 5.1 | 11.5 | 6.1 | 12.0 |
35/39/51/56/59 | 14.0 | 16.9 | 21.7 | 17.7 | 5.1 | 19.0 | 5.7 | 19.5 |
6/11/16/18/31/33/45/52/58 | 16.4 | 19.3 | 29.2 | 20.9 | 7.6 | 15.0 | 8.6 | 20.5 |
“HPV”: human papillomavirus.